Related Experiment Video

Updated: Jun 14, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

p53 inactivation by MDM2 and MDMX negative feedback loops in testicular germ cell tumors

Baozong Li1, Qian Cheng, Zhenyu Li

  • 1Molecular Oncology Department, Moffitt Cancer Center, Tampa, FL, USA.

Cell Cycle (Georgetown, Tex.)
|April 8, 2010
PubMed

Insights

Testicular germ cell tumors (TGCT) show p53 inactivation due to MDM2 and MDMX. Targeting these proteins activates p53, inducing apoptosis and offering a potential treatment for drug-resistant TGCT.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Testicular germ cell tumors (TGCT) exhibit exceptional sensitivity to DNA-damaging chemotherapy.
  • p53 mutations are infrequent in TGCT, indicating an alternative p53 inactivation mechanism.
  • A TGCT-specific pathway for p53 inactivation has been previously suggested.

Purpose of the Study:

  • To investigate the role of MDM2 and MDMX in p53 inactivation in TGCT.
  • To explore the therapeutic potential of targeting p53-MDM2/MDMX interactions in TGCT.

Main Methods:

  • Utilized Nutlin, an MDM2-specific inhibitor, to disrupt p53-MDM2 binding.
  • Performed MDMX knockdown experiments.
  • Analyzed MDMX mRNA and protein expression following p53 activation.
  • Identified and characterized a p53-responsive promoter in the MDMX gene.

Main Results:

  • Nutlin treatment activated p53 in TGCT cells, inducing significant apoptosis.
  • MDMX knockdown enhanced p53 activation when combined with Nutlin.
  • p53 activation led to a two-fold increase in MDMX expression.
  • A functional p53-binding site within MDMX intron 1 suggests a negative feedback loop.

Conclusions:

  • MDM2 and MDMX are key factors in the functional inactivation of p53 in TGCT.
  • TGCT cells demonstrate a robust apoptotic response to p53 activation.
  • Targeting MDM2 and MDMX offers a promising therapeutic strategy for TGCT, particularly for cases resistant to conventional chemotherapy.

More Related Videos

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer08:34

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...